Untargeted fecal metabolome analysis in obese dogs after weight loss achieved by feeding a high-fiber-high-protein diet
-
Published:2021-07
Issue:7
Volume:17
Page:
-
ISSN:1573-3882
-
Container-title:Metabolomics
-
language:en
-
Short-container-title:Metabolomics
Author:
Bermudez Sanchez SandraORCID, Pilla Rachel, Sarawichitr Benjamin, Gramenzi Alessandro, Marsilio Fulvio, Steiner Joerg M., Lidbury Jonathan A., Woods Georgiana R. T., Suchodolski Jan S., German Alexander J.
Abstract
Abstract
Introduction
In humans and companion animals, obesity is accompanied by metabolic derangements. Studies have revealed differences in the composition of the fecal microbiome between obese dogs and those with an ideal body weight.
Objectives
We have previously reported that the fecal microbiome in obese dogs changes after controlled weight reduction, induced by feeding a diet high in fiber and protein. Despite these findings, it is unclear if taxonomic differences infer differences at the functional level between obese dogs and those with an ideal body weight.
Methodology
Untargeted fecal metabolome analysis was performed on dogs with obesity before and after weight loss achieved by feeding a high-fiber-high-protein diet.
Results
Fecal metabolome analysis revealed a total of 13 compounds that changed in concentration in obese dogs after weight loss. Of these compounds, metabolites associated with bacterial metabolism decreased after weight loss including purine, L-(-)-methionine, coumestrol, and the alkaloids 1-methylxanthine and trigonelline. Conversely, the polyphenols (-)-epicatechin and matairesinol and the quinoline derivatives 1,5-isoquinolinediol and 2-hydroxiquinoline increased after weight loss.
Conclusion
These results suggest differences in intestinal microbiome at the functional level after weight loss, but further studies are needed to determine the role of these compounds in the etiology of obesity and weight loss.
Funder
Mars Petcare H2020 Marie Skłodowska-Curie Actions
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference68 articles.
1. Ables, G. P., Perrone, C. E., Orentreich, D., & Orentreich, N. (2012). Methionine-restricted C57BL/6J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. PLoS ONE, 7, e51357. 2. Agus, A., Planchais, J., & Sokol, H. (2018). Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host & Microbe, 23, 716–724. 3. Anwar, S., Bhandari, U., Panda, B. P., Dubey, K., Khan, W., & Ahmad, S. (2018). Trigonelline inhibits intestinal microbial metabolism of choline and its associated cardiovascular risk. Journal of Pharmaceutical and Biomedical Analysis, 159, 100–112. 4. Arora, T., Sharma, R., & Frost, G. (2011). Propionate. Anti-obesity and satiety enhancing factor? Appetite, 56, 511–515. 5. Badgujar, P. C., Jain, S. K., Singh, A., Punia, J. S., Gupta, R. P., & Chandratre, G. A. (2013). Immunotoxic effects of imidacloprid following 28 days of oral exposure in BALB/c mice. Environmental Toxicology and Pharmacology, 35, 408–418.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|